Status:
ACTIVE_NOT_RECRUITING
Increasing Screening for Cancer Using EHR-Nudges Replication
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-74 years
Phase:
NA
Brief Summary
In this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visi...
Detailed Description
Cancer is a leading cause of mortality in the United States. While strong USPSTF guideline recommendations support appropriate screening for early detection and to avoid preventable deaths, breast can...
Eligibility Criteria
Inclusion
- All patients must meet the following criteria to be eligible:
- Women between 40 and 74 years of age
- A scheduled new or return (non-urgent/sick) primary care visit at one of the study practices at Lancaster General Health
- Are overdue and eligible for a mammogram per Epic Health Maintenance
- Does not have a future scheduled mammogram appointment
- Patients meeting at least one of the following criteria will be considered high risk for screening non-completion:
- Medicare Insurance
- Medicaid Insurance
- No EHR patient portal account
- Zero log-ins to EHR patient portal in the previous year
Exclusion
- Patients will be excluded from the study if they:
- Have a history of bilateral mastectomy, breast cancer, or metastatic cancer
- Have a mammogram exclusion modifier in Health Maintenance
- Have no phone number (home or mobile) listed in their chart
Key Trial Info
Start Date :
June 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 2 2026
Estimated Enrollment :
7920 Patients enrolled
Trial Details
Trial ID
NCT06995703
Start Date
June 2 2025
End Date
June 2 2026
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lancaster General Health
Lancaster, Pennsylvania, United States, 17602